InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: PPHMownsME post# 173439

Thursday, 04/17/2014 12:57:22 PM

Thursday, April 17, 2014 12:57:22 PM

Post# of 345786

We were trading over $3 then and it was shortly after the RS. I don't know how to look up historical share counts, but I bet it was close to 1/3 of what we have outstanding now.



I will completely agree with you there, that the O.S. shares were in the range of 1/3 of where we sit today.

...but we must also take into consideration now we depth and paradigm shifting qualities that purely exist within the PS Targeting Platform of Technologies as a whole. I've always said that 100M .. or 200M ... or 300M .. or 400M shares is simply not enough once Peregrine Pharmaceuticals gets in gear. We must also consider how there is not a large pool of small biotechs that manufacture their own product and there are "absolutely no biotechs" that have ever pulled off a preferred share offering as Peregrine just completed.

Wouldn't be true to say that if the value of a company goes down, then it should go down on PPHM, as well as PPHMP ? This simply shows that those holding PPHMP know exactly what they have and those preferred shares have not been infiltrated to abuse, such as the common share base has been ever since Black Monday and 200M shares traded hands.

Its a process for Peregrine to get back on their feet and unfortunately, there are Federal Authorities involved as well-- SK publicly told everyone at the ASM that all info was handed over to "several Federal Authorities". SK also is now showing signs of more confidence than ever to call out CSM in the response to the lawsuit with "enough" details to get some people squirming. Its the details that are left out and will probably always will be left out, never to be heard about again that remains their Ace Card in their back pocket as they push the PS Targeting Platform of Technologies forward with the help of K&L Gates Law Firm.

There have been soo many clues and pieces of the puzzle that we continue to stumble upon that makes Peregrine the biotech values leader at this point in time. We are only a couple of announcements away from plowing ahead to new highs. A few of my top announcements are:

1) CSM lawsuit settled
2) CA lawsuit dismissed
3) some type of milestone... and PPHM options announced?
4) Patent updates
5) ASCO

lets see if Peregrine gives us a little easter egg this weekend that we can speculate some big news on

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News